Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Hypertensive Population Under Treatment With Micardis in Real Clinical Conditions With the Goal to Control the Early Morning BP Rise

NCT00946829 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT00946829
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00946829 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Hypertensive Population Under Treatment With Micardis in Real Clinical Conditions With the Goal to Control the Early Morning BP Rise
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Completed
Start date
January 31, 2003
Completion date
Not reported
Enrollment
18,299 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension